Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

46 Stocks Moving in Wednesday's Pre-Market Session

Author: Lisa Levin | December 16, 2020 08:02am

Gainers

  • Neovasc Inc. (NASDAQ:NVCN) rose 109% to $1.63 in pre-market trading. Neovasc, on Tuesday, said it has received written notification from the Nasdaq that the company is not in compliance with the minimum bid price requirement set forth in Nasdaq Rules for continued listing on the Nasdaq. The company has been given until June 14, 2021 to regain compliance. The company also said it has completed the first three Neovasc Reducer™ implants in France..
  • Sio Gene Therapies, Inc. (NASDAQ:SIOX) rose 38.7% to $3.94 in pre-market trading after the company disclosed "positive" six-month follow-up data from a low-dose cohort of Phase 1/2 trial of AXO-AAV-GM1.
  • Bridgetown Holdings Limited (NASDAQ:BTWN) rose 30% to $14.50 in pre-market trading. Bridgetown Holdings shares climbed over 22% on Tuesday on reports the SPAC is considering a merger with PT Tokopedia.
  • New Providence Acquisition Corp. (NASDAQ:NPA) shares rose 26% to $13.00 in pre-market trading.
  • BioLineRx Ltd. (NASDAQ:BLRX) rose 21.8% to $4.41 in pre-market trading after the company reported final results from Phase 2a COMBAT/KEYNOTE-202 triple combination study of motixafortide in second line metastatic pancreatic cancer.
  • Tilray, Inc. (NASDAQ:TLRY) rose 21% to $9.52 in pre-market trading on reports the company is in advanced merger talks with Aphria.
  • UroGen Pharma Ltd. (NASDAQ:URGN) rose 19.3% to $22.00 in pre-market trading.
  • Liquidia Corporation (NASDAQ:LQDA) shares rose 18.2% to $3.45 in pre-market trading. Liquidia, on Monday, reported a CEO transition.
  • Code Chain New Continent Limited (NASDAQ:CCNC) rose 17.3% to $2.24 in pre-market trading after climbing over 22% on Tuesday.
  • MIND Technology, Inc. (NASDAQ:MIND) rose 15.8% to $2.05 in pre-market trading after declining 28% on Tuesday. MIND Technology, earlier during the month, posted a Q3 loss.
  • Drive Shack Inc. (NYSE:DS) rose 13.1% to $2.77 in pre-market trading. Drive Shack is scheduled to reopen its Orlando venue on December 18th.
  • Aphria Inc. (NASDAQ:APHA) rose 12.3% to $9.12 in pre-market trading on reports the company is in advanced merger talks with Tilray.
  • Hancock Jaffe Laboratories Inc (NASDAQ:HJLI) rose 12.1% to $12.04 in pre-market trading after the company reported "significant improvements" in all study endpoints for final VenoValve first-in-human data.
  • American Outdoor Brands, Inc. (NASDAQ:AOUT) shares rose 11.7% to $17.70 in pre-market trading after the company reported upbeat Q2 results and issued strong FY21 forecast.
  • Cellectis S.A. (NASDAQ:CLLS) rose 10.3% to $28.52 in pre-market trading. Cellectis shares fell 17% on Tuesday after the company reported a $100 million ADS offering.
  • Hexindai Inc. (NASDAQ:HX) rose 10.3% to $2.89 in pre-market trading after the company reported the sale of its P2P business for RMB 5 million.
  • Liquidia Corporation (NASDAQ:LQDA) rose 9.6% to $3.20 in pre-market trading. Liquidia, on Monday, reported a CEO transition.
  • New Providence Acquisition Corp. (NYSE:NPA) rose 9.6% to $11.31 in pre-market trading.
  • R. R. Donnelley & Sons Company (NYSE:RRD) shares rose 9.1% to $1.92 in pre-market trading after gaining over 9% on Tuesday. R.R. Donnelley, last week, reported a vaccination distribution toolkit to support marketing and operations for pending COVID-19 vaccine.
  • Good Times Restaurants Inc (NASDAQ:GTIM) rose 8.1% to $2.13 in pre-market trading after reporting a rise in Q4 earnings.
  • DAVIDsTEA Inc. (NASDAQ:DTEA) rose 8% to $2.16 in pre-market trading after the company swung to a profit in the third quarter.
  • Apollo Endosurgery, Inc. (NASDAQ:APEN) rose 7% to $4.13 in pre-market trading after the company disclosed that it has received the FDA clearance for the X-Tack Endoscopic HeliX Tacking System.
  • Allied Esports Entertainment Inc. (NASDAQ:AESE) rose 6.7% to $1.75 in pre-market trading after gaining around 9% on Tuesday.
  • Polar Power, Inc. (NASDAQ:POLA) rose 6.7%to $5.00 in pre-market trading after gaining 20% on Tuesday.
  • WISeKey International Holding AG (NASDAQ:WKEY) rose 6.4% to $5.83 in pre-market trading. WISeKey International, on Monday, reported the launch of IoT partnerships via the Trust Protocol Association to monetize its intellectual property portfolio, including both patent and data assets.
  • Immutep Limited (NASDAQ:IMMP) rose 5.5% to $3.64 in pre-market trading. Immutep shares gained 15% on Tuesday after the company issued an update on 6 clinical trials.
  • BioCardia, Inc. (NASDAQ:BCDA) rose 5.4% to $7.06 in pre-market trading after climbing around 50% on Tuesday. BioCardia reported a 1.789 million share registered direct offering priced at $4.75 per share. The company recently said it anticipates data safety monitoring board verbal feedback by the end of Dec. 15 for its pivotal Phase 3 CardiAMP Heart Failure Trial.
  • Baidu, Inc. (NASDAQ:BIDU) rose 4.6% to $194.02 in pre-market trading. Baidu shares surged around 14% on Tuesday following reports of the Chinese search giant's interest in the lucrative field of electric vehicle manufacturing.


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • vTv Therapeutics Inc. (NASDAQ:VTVT) fell 26.6% to $2.18 in pre-market trading. VTv Therapeutics, on Tuesday, announced it entered into a licensing agreement with Anteris Bio for worldwide rights to vTv's novel clinical-stage Nrf2 activator compound, HPP971.
  • Concord Medical Services Holdings Limited (NYSE:CCM) shares fell 24.7% to $4.00 in pre-market trading after surging over 179% on Tuesday.
  • Galapagos NV (NASDAQ:GLPG) fell 15.4% to $101.11 in pre-market trading after after its partner Gilead said it will not pursue the U.S. FDA Approval of its rheumatoid arthritis treatment filgotinib.
  • ENDRA Life Sciences Inc. (NASDAQ:NDRA) fell 14.4% to $0.6980 in pre-market trading after the company reported pricing of public offering of common stock.
  • Xcel Brands, Inc. (NASDAQ:XELB) fell 14.4% to $1.13 in pre-market trading after surging around 19% on Tuesday.
  • Penumbra, Inc. (NYSE:PEN) fell 11.6% to $167.00 in pre-market trading after the company announced it is voluntarily recalling all configurations of the Penumbra JET 7 Reperfusion Catheter with Xtra Flex technology.
  • ChromaDex Corporation (NASDAQ:CDXC) fell 10% to $4.70 in pre-market trading.
  • Mid-Con Energy Partners, LP (NASDAQ:MCEP) fell 10% to $3.78 in pre-market trading after climbing 11% on Tuesday.
  • Greenwich LifeSciences, Inc. (NASDAQ:GLSI) shares fell 9.9% to $47.65 in pre-market trading after the company files for offering of 470,085 shares of its common stock. Greenwich LifeSciences shares jumped 13% on Tuesday after the company announced it entered an option agreement with Westport Bio to in-license a pre-clinical coronavirus vaccine program.
  • Patriot Transportation Holding, Inc. (NASDAQ:PATI) fell 9.1% to $11.00 in pre-market trading.
  • GeoVax Labs, Inc. (NASDAQ:GOVX) fell 7.9% to $3.40 in pre-market trading after climbing around 14% on Tuesday. GeoVax, last month, reported a license agreement with NIH To 'support continued advancements in vaccine development.'
  • Anchiano Therapeutics Ltd. (NASDAQ:ANCN) fell 7.3% to $2.67 in pre-market trading. Anchiano Therapeutics shares jumped 87% on Tuesday after the company announced a merger agreement with Chemomab.
  • iQIYI, Inc. (NASDAQ:IQ) fell 7.2% to $20.70 in pre-market trading as the company after the company announced a proposed offering of convertible senior notes and American Depositary Shares.
  • Verastem, Inc. (NASDAQ:VSTM) fell 6.8% to $2.06 in pre-market trading. Verastem Oncology, on Tuesday, initiated Phase 2 registration-directed trial of VS-6766 and defactinib in previously treated KRAS mutant non-small cell lung cancer.
  • Apartment Investment and Management Company (NYSE:AIV) fell 6.7% to $4.70 in pre-market trading. Apartment Investment and Management shares tumbled 86% on Tuesday after the company announced it completed the separation of its businesses, making Apartment Income REIT a separate, publicly-traded company.
  • SharpSpring, Inc. (NASDAQ:SHSP) fell 6.7% to $14.80 in pre-market trading after reporting a proposed offering of common stock.
  • Recro Pharma, Inc. (NASDAQ:REPH) shares fell 6.6% to $2.83 in pre-market trading after declining around 12% on Tuesday.
  • DISH Network Corporation (NASDAQ:DISH) fell 4% to $34.30 in pre-market trading following news of a convertible notes offering.

Posted In: AESE AIV ANCN AOUT APEN APHA BCDA BIDU BLRX BTWN CCM CCNC CDXC CLLS DISH DS DTEA GLPG GLSI GOVX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist